Literature DB >> 2448220

Feto-maternal transfusion after chorionic villus sampling. Evaluation by maternal serum alphafetoprotein measurement.

W Fuhrmann1, K Altland, A Köhler, W Holzgreve, V Jovanović, R Rauskolb, I H Pawlowitzki, P Miny.   

Abstract

The alphafetoprotein (AFP) concentration in maternal serum was determined before and after chorionic villus sampling (CVS). A significant increase of 20% or more in the pre-CVS level was noted immediately after sampling in 59% of 837 pregnancies indicating some degree of feto-maternal haemorrhage. The increase in the AFP concentration in maternal serum was correlated with the weight of the tissue sample but not with the number of sampling attempts. A correlation of AFP increase and frequency of spontaneous abortions following CVS was suggested only in the group with an AFP increase of more than 100% or with a continuing rise in the first hour following CVS. CVS in early pregnancy obviously did not interfere with maternal serum AFP screening for neural tube defects in the second trimester. Although AFP measurement before and after CVS seems to have no immediate diagnostic application, in the research phase of CVS it may help to identify those procedures that are the least traumatic.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2448220     DOI: 10.1007/bf00291241

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  4 in total

1.  Chorionic villi sampling changes maternal serum alpha-fetoprotein.

Authors:  F G Mariona; R Bhatia; F N Syner; F Koppitch
Journal:  Prenat Diagn       Date:  1986 Jan-Feb       Impact factor: 3.050

2.  Does chorionic villus sampling cause fetomaternal haemorrhage?

Authors:  R C Warren; J Butler; J M Morsman; C McKenzie; C H Rodeck
Journal:  Lancet       Date:  1985-03-23       Impact factor: 79.321

3.  Feto-maternal transfusion after chorionic villus sampling: clinical implications.

Authors:  B Brambati; S Guercilena; I Bonacchi; A Oldrini; A Lanzani; L Piceni
Journal:  Hum Reprod       Date:  1986-01       Impact factor: 6.918

4.  Chorionic villi sampling: clinical experience, immediate complications, and patient attitudes.

Authors:  T B Perry; M J Vekemans; A Lippman; E F Hamilton; P J Fournier
Journal:  Am J Obstet Gynecol       Date:  1985-01-15       Impact factor: 8.661

  4 in total
  1 in total

1.  Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci.

Authors:  Bernhard Zimmermann; Matthew Hill; George Gemelos; Zachary Demko; Milena Banjevic; Johan Baner; Allison Ryan; Styrmir Sigurjonsson; Nikhil Chopra; Michael Dodd; Brynn Levy; Matthew Rabinowitz
Journal:  Prenat Diagn       Date:  2012-10-30       Impact factor: 3.050

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.